High-frequency Electrical Stimulation Helps Reduce Inflammation, Pain in New Feinstein Institutes Study

MANHASSET, N.Y.–(BUSINESS WIRE)–A bump, bruise or broken bone is painful. And while pain is an important defense mechanism to protect the body and promote healing, chronic pain can be debilitating. In the United States alone, 20-50 million adults suffer from chronic pain. New research published by scientists at The Feinstein Institutes for Medical Research in … [Read more…]

AbCellera Announces Presentation of Data from CD3 T-Cell Engager Platform at SITC 2022

VANCOUVER, British Columbia–(BUSINESS WIRE)–$ABCL—AbCellera (Nasdaq: ABCL) today announced a presentation at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, to be held virtually and at the Boston Convention & Exhibition Center from November 8 to 12, 2022. “T-cell engagers have tremendous potential as precision oncology therapeutics by redirecting cancer-killing T cells to specific … [Read more…]

Thermo Fisher Scientific Announces New Cryo-TEM with Expansive Automation Features to Help Accelerate Drug Discovery Research

Thermo Scientific Glacios 2 Cryo-TEM designed to be the next evolution in cryo-electron microscopy with enhanced throughput and high-resolution imaging capabilities HILLSBORO, Ore.–(BUSINESS WIRE)–#cryoEM–Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific Glacios 2 Cryo-Transmission Electron Microscope (Cryo-TEM), a powerful microscope with new automation and high-resolution imaging capabilities designed … [Read more…]

Second Annual RARE Health Equity Summit Addresses Gaps in Access, Shares Approaches to Build Inclusiveness in Underserved Communities

Event will Highlight and Explore Collaborative Efforts to Overcome Inequities Faced by Minoritized Communities ALISO VIEJO, Calif.–(BUSINESS WIRE)–Global Genes, a leading rare disease advocacy organization, will hold its second annual RARE Health Equity Summit in partnership with the Rare Disease Diversity Coalition (RDDC). The event includes speakers from the FDA, community and patient organizations, academia … [Read more…]

IconOVir Bio to Present Preclinical Data on Lead Candidate ICVB-1042 at SITC 2022

SAN DIEGO, Calif.–(BUSINESS WIRE)–IconOVir Bio, Inc. (IconOVir), a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus (OV) therapy to improve the treatment of patients with cancer, today announced that it will present preclinical data on ICVB-1042 in three poster presentations at the upcoming Annual Meeting of the Society for Immunotherapy of Cancer (SITC … [Read more…]

Apnimed Expands Senior Leadership Team by Appointing John Cronin, M.D., Senior Vice President, Clinical Development

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Apnimed, a clinical-stage company focused on advancing pharmacologic treatments for obstructive sleep apnea and related disorders, today announced that John Cronin, M.D., has joined the company as Senior Vice President, Clinical Development. Dr. Cronin has nearly three decades of experience as a leader in clinical sleep medicine and in commercial solutions to sleep … [Read more…]

Valence Discovery Grows Leadership Team with Key Drug Discovery Hires

Following successful partnerships with leading biotech and pharmaceutical companies, Valence adds industry veterans to its leadership team to support development of its in-house drug discovery pipeline MONTREAL & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#AI—Valence Discovery (“Valence”), a leader in AI-driven drug discovery harnessing the power of computation and fit-for-purpose data generation to design differentiated small molecules, announced today … [Read more…]

US T-Cell Leukemia Market and Competitive Landscape – 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US T-Cell Leukemia Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. The report US T-Cell Leukemia Market and Competitive Landscape Highlights – 2022, provides comprehensive insights into T-Cell Leukemia pipeline products, T-Cell Leukemia epidemiology, T-Cell Leukemia market valuations and forecast, T-Cell Leukemia drugs sales and competitive landscape in … [Read more…]

Continuous Glucose Monitoring (CGM) Market to Grow by 13% Annually Through 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Continuous Glucose Monitoring (CGM) Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The Continuous Glucose Monitoring (CGM) Market is expected to register a CAGR greater than 13% over the forecast period, 2022-2027. Governments around the world developed programs to educate diabetes patients and … [Read more…]

Global Oncology Based In-Vivo CRO Market Report 2022: Rising Outsourcing from Pharma Companies Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Oncology Based In-Vivo CRO Market Analysis, By Model, By Indication, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The oncology based in-vivo CRO market size is estimated to be USD 998.96 million in 2021 and is expected to witness a CAGR of 8.75% during the forecast … [Read more…]